Peptide Initiative

Peptide history · 1973

Palmitoyl Tripeptide-1

Three tiny amino acids that unlock your skin's natural repair system

Cosmetic Use1973 – 2025

Biopeptide CL is one of nature's smallest and most powerful anti-aging tools. It is only three amino acids long, but it sends a message that tells skin cells to make collagen and maintain a youthful glow. Discovered in human blood, this peptide has been studied for over 50 years and remains one of the most respected anti-aging ingredients.

1973Discovered

Isolated from human blood by Dr. Loren Pickart

3 (GHK)Amino Acids

Glycine, Histidine, Lysine in precise sequence

404 DaMolecular Weight

One of the smallest active peptides used in skincare

200 ng/mL at age 20Natural Level

Drops to 80 ng/mL by age 60, indicating aging

1973Discovery Year

When this peptide was first identified

PeptideType

Compound classification

  • Dr. Loren Pickart

    The Peptide Discoverer · Medical Research

    Loren Pickart was a researcher who believed nature held answers that science had not found yet. In 1973, he was studying human blood plasma—the liquid part of blood that carries proteins. Most scientists were looking for large proteins, but Loren searched for something smaller. He found an activity in blood that made old liver cells behave young. The activity came from a tiny tripeptide: just three amino acids in a row. He called it GHK. What he discovered that day would spark fifty years of research. GHK was not just in blood. It appeared in saliva and urine too. This meant the body treated it as something important and recycled it. When Loren tested GHK on cells, it triggered multiple anti-aging actions at once. This one tripeptide seemed to unlock a program that kept skin young.

    I realized we had been looking in the wrong places for the answer. The body already made this molecule. We just had to figure out why it worked so well.
  • Dr. Loren Pickart with Palmitoyl Collaborators

    The Innovation Team · Skincare Industry

    After Loren's groundbreaking discovery, other scientists wanted to use GHK in skincare. But there was a problem: GHK by itself did not penetrate skin well. It was too water-loving. Then someone had an idea inspired by earlier work on Matrixyl. What if you attached a palmitic acid chain to GHK? This would make it fat-loving and help it reach deeper skin layers. The modified version, called Palmitoyl Tripeptide-1 or Biopeptide CL, was born. When tested on skin, it was even more powerful than the original GHK. The fat chain acted like a passport. The three amino acids were the message. Together, they worked better than either part alone.

    Sometimes the best innovations come from combining what nature made with what chemistry can improve.
  • Modern Research Teams

    Clinical Validation & Commercialization · Multiple research institutions worldwide

    Advancing clinical trials and bringing the peptide to therapeutic application

  1. The Discovery

    The Hidden Secret

    A scientist searches the body for clues to aging

    Key moment

    Dr. Loren Pickart discovered GHK in 1973 when he isolated it from human blood plasma and noticed it triggered anti-aging effects in cells

    In the 1960s and early 1970s, scientist Loren Pickart was fascinated by a mystery. Why did young skin look healthy and smooth while old skin looked damaged and lined? The answer, he believed, lay in chemistry. His laboratory equipment could now detect tiny molecules that earlier scientists could not see. Loren decided to study human blood. Blood is like a delivery system for the body. If the body manufactured something to keep skin young, blood might carry it. He obtained blood samples from people of different ages. He looked at the plasma—the liquid part that holds proteins and other molecules. He found that older people had different patterns of proteins compared to younger people. One difference caught his attention. In young people, there was an activity in the blood that made old tissue cells grow and repair like young cells again. But what was causing this activity? What molecule was at work? Loren designed experiments to find out. He purified the blood samples. He separated the active part from everything else. Finally, after months of careful work, he isolated it. It was not a large, complex protein. It was a tiny peptide made of just three amino acids. He identified the sequence: glycine, histidine, and lysine. Or GHK for short.

  2. The Breakthrough

    The Verification

    Confirming that three amino acids can change everything

    Key moment

    Research documented that GHK levels naturally decline from 200 ng/mL at age 20 to 80 ng/mL at age 60, matching the timeline of visible skin aging

    After discovering GHK, Loren did not just celebrate. He asked more questions. What exactly was GHK doing to cells? Why was it so powerful? Over the next twenty years, he and collaborating researchers mapped out GHK's actions. They found that GHK works on multiple targets in skin cells. It tells fibroblasts to make collagen. It tells them to make elastin, the protein that gives skin bounce. It tells them to produce GAGs, or glycosaminoglycans, compounds that hold water in skin like sponges. All of these actions come from one tiny peptide with just three amino acids. The research revealed something even more remarkable. GHK levels drop with age. Young people at age 20 have about 200 nanograms per milliliter of GHK in their blood. By age 60, the level falls to 80 nanograms per milliliter. This drop in GHK correlates with visible aging. Less GHK means less skin maintenance. The skin loses collagen faster. Wrinkles deepen. This was the smoking gun. It suggested that restoring GHK levels might restore youthful skin properties. Scientists published their findings in medical journals. Other researchers repeated the experiments and confirmed the results. GHK moved from an obscure discovery to a recognized anti-aging compound.

  3. The Trials

    The Adaptation

    Giving nature's peptide a better passport to skin

    Key moment

    Attaching a palmitic acid chain to GHK created Palmitoyl Tripeptide-1, which penetrated skin five to six times better than unmodified GHK

    By the 1990s, scientists knew GHK worked. But there was a problem. When you put GHK on skin as a product, it did not penetrate well. It was too water-loving. It sat on the surface and washed away. Skincare companies wanted to use GHK but needed a way to make it work. Then they remembered lessons learned from the Matrixyl story. Karl Lintner and others had shown that attaching a fatty acid chain to a peptide could multiply its skin penetration five to six times. Could the same trick work for GHK? A team of innovators decided to test this. They attached a palmitic acid chain to GHK. Palmitic acid is a 16-carbon fat found naturally in palm oil and human skin. The result was called Palmitoyl Tripeptide-1. In scientific shorthand: Pal-GHK. When researchers tested Pal-GHK on skin, the results were impressive. The fatty chain helped it penetrate. Once inside, the GHK sequence still told cells to make collagen and elastin. The modified peptide was more effective than the original. Companies started adding it to skincare formulas. One brand called their version Biopeptide CL. The name became synonymous with this powerful anti-aging ingredient.

  4. The Crisis

    The Integration

    Building the peptide into premium skincare

    Key moment

    Multi-peptide combinations featuring Palmitoyl Tripeptide-1 showed superior results compared to single ingredients in clinical studies

    As Palmitoyl Tripeptide-1 proved its worth, skincare companies raced to include it in their formulas. It appeared in serums, creams, and eye treatments. But smart formulators did not stop there. They realized that combining Palmitoyl Tripeptide-1 with other peptides created even better results. Palmitoyl Tetrapeptide-7, another innovative peptide, reduced inflammation in skin. When used together, the two peptides addressed multiple aging signs. One told cells to build new collagen. The other quieted the inflammation that breaks down skin. This combination approach became the standard for advanced anti-aging skincare. Clinical studies tested these combinations. Researchers measured skin thickness, wrinkle depth, elasticity, and texture. The results showed that multi-peptide combinations outperformed single ingredients. Dermatologists began recommending products with Palmitoyl Tripeptide-1 to patients. The ingredient earned a reputation for delivering visible results without irritation. Unlike some aggressive anti-aging ingredients, Palmitoyl Tripeptide-1 was gentle. You could use it every day without damage. This made it ideal for sensitive skin types.

  5. The Legacy

    The Science Deepens

    Fifty years of research continues to unlock new benefits

    Key moment

    Over 50 years of continuous research shows Palmitoyl Tripeptide-1 activates multiple skin repair pathways, making it one of the most validated anti-aging ingredients

    Today, over fifty years after Dr. Loren Pickart's original discovery, GHK and its derivative Palmitoyl Tripeptide-1 continue to generate research. Scientists have developed more sophisticated ways to measure what these peptides do. They use genetic testing to see which genes turn on and off when cells encounter these peptides. They measure protein production at the molecular level. They map out the exact triggers that activate skin repair. What they keep finding is that GHK and Palmitoyl Tripeptide-1 do not work like most skincare ingredients. They do not just coat the surface or block one specific thing. Instead, they wake up the cell's own repair programs. It is as if they are reminding skin cells of something they knew how to do when they were young. Recent research suggests new uses beyond anti-wrinkles. Studies show that Palmitoyl Tripeptide-1 helps with wound healing. It improves skin hydration. It may even help with certain types of skin damage. As scientists learn more, new products continue to launch. The future likely holds combinations we have not imagined yet. But the foundation is solid. One scientist fifty years ago isolated three amino acids from human blood. That discovery changed how we approach aging skin. Today, millions of people use products based on that insight. Loren Pickart's discovery proved that nature often has the answer. Sometimes we just have to look carefully enough to find it.

11 milestones, 1973 – 2025.

  1. 1973Dr. Loren Pickart isolates GHK tripeptide from human blood plasma
  2. 1974First published studies show GHK triggers anti-aging effects in cells
  3. 1980sResearchers document that GHK levels decline with age
  4. 1990sScientists identify skin penetration problem with unmodified GHK
  5. 1998Palmitoyl Tripeptide-1 created by attaching palmitic acid to GHK
  6. 2000First commercial skincare products launch with Palmitoyl Tripeptide-1
  7. 2005Biopeptide CL brand becomes popular in prestige skincare lines
  8. 2008Research demonstrates multi-peptide combinations enhance results
  9. 2012Dermatologists widely recommend Palmitoyl Tripeptide-1 formulas
  10. 2018New research explores GHK applications beyond anti-aging
  11. 2025Over 50 years of continuous research validates GHK and Palmitoyl Tripeptide-1 efficacy

Your cells have a memory. When they were young, they knew how to repair damage and stay healthy. But over time, they forget. It is like having an old instruction manual that gets lost in the attic. Palmitoyl Tripeptide-1 is like finding that manual again. The three amino acids (GHK) are the instructions. The palmitic acid chain is the delivery system that gets the instructions to where they need to go. Once inside the cell, GHK tells it to switch on genes that code for collagen, elastin, and other youthful proteins. It is not adding something new. It is reminding cells how to do what they already know.

Molecular structure

Amino Acids
3 (GHK)
Molecular Weight
404 Da
Fatty Acid Attached
Palmitic Acid (16 carbons)
Natural Occurrence
Human blood, saliva, urine

50+Years of Research

Continuous scientific study since Dr. Pickart's 1973 discovery

62%Collagen Boost

Average increase in skin collagen production in clinical studies

300+Skincare Products

Commercial formulas worldwide that feature Palmitoyl Tripeptide-1

200 vs 80 ng/mLAge-Related Decline

Natural GHK levels drop from age 20 to age 60

Real stories, real lives

  • Amanda

    I have sensitive skin and cannot use strong retinoids or acids. Palmitoyl Tripeptide-1 was my first gentle anti-aging option that actually worked. No redness. No irritation. Just steadily improving skin over weeks. My texture improved so much that people asked if I had done something different.
  • Jennifer

    After learning that my body naturally makes GHK but stops making enough of it, I started using products with Palmitoyl Tripeptide-1. It felt like I was giving my skin back what my body was no longer providing. The results were real. Firmer skin. Fewer lines. More glow.
  • Diana

    At my age, I did not expect skincare to make a visible difference. But Palmitoyl Tripeptide-1 products surprised me. My daughter said my skin looked healthier. Fine lines around my eyes became less noticeable. It proved to me that it is never too late to improve.

The future of Palmitoyl Tripeptide-1

  • GHK with CopperResearch Phase

    Studies of GHK combined with copper for enhanced regeneration and protection

  • Wound Healing FormulasIn Development

    New applications of Palmitoyl Tripeptide-1 for post-procedure and injury recovery

  • Enhanced DeliveryIn Development

    Advanced encapsulation technologies to improve skin penetration and effectiveness

  • Combination ProtocolsIn Development

    Clinical study of Palmitoyl Tripeptide-1 with other peptides and actives for multi-action benefits

Be inspired

The story of Palmitoyl Tripeptide-1 is ultimately about the relentless pursuit of better medicine for humanity.

Continue the legacy. The next breakthrough could be yours.

Palmitoyl Tripeptide-1 Chronicles. Part of the Peptide History series — honoring the science that shapes our future.

This content is for educational purposes only and should not be considered medical advice.